# GeneDx Shares Slide as Fourth-Quarter Revenue Outlook Misses Estimates

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/53919
Published: 2026-11-11T12:11:03.000Z
Updated: 2026-11-11T12:11:03.000Z
Section: Business

> Third-quarter 2026 revenue exceeded consensus estimates, while the next-quarter forecast fell below market expectations.

GeneDx Holdings Corp. (WGS) shares declined in premarket trading Tuesday, Nov. 10, after the genetic testing company issued a fourth-quarter revenue outlook below market expectations. Third-quarter 2026 revenue exceeded consensus estimates.